Dolcetti R - Search Results

1

Functional avidity-driven activation-induced cell death shapes CTL immunodominance.

Dalla Santa S, Merlo A, Bobisse S, Ronconi E, Boldrin D, Milan G, Barbieri V, Marin O, Facchinetti A, Biasi G, Dolcetti R, Zanovello P, Rosato A. Dalla Santa S, et al. Among authors: dolcetti r. J Immunol. 2014 Nov 1;193(9):4704-11. doi: 10.4049/jimmunol.1303203. Epub 2014 Sep 22. J Immunol. 2014. PMID: 25246498

2

Virus-specific cytotoxic CD4+ T cells for the treatment of EBV-related tumors.

Merlo A, Turrini R, Bobisse S, Zamarchi R, Alaggio R, Dolcetti R, Mautner J, Zanovello P, Amadori A, Rosato A. Merlo A, et al. Among authors: dolcetti r. J Immunol. 2010 May 15;184(10):5895-902. doi: 10.4049/jimmunol.0902850. Epub 2010 Apr 12. J Immunol. 2010. PMID: 20385879

3

Differential down-modulation of HLA class I and II molecule expression on human tumor cell lines upon in vivo transfer.

Turrini R, Merlo A, Dolcetti R, Zanovello P, Rosato A. Turrini R, et al. Among authors: dolcetti r. Cancer Immunol Immunother. 2011 Nov;60(11):1639-45. doi: 10.1007/s00262-011-1086-3. Epub 2011 Aug 11. Cancer Immunol Immunother. 2011. PMID: 21833593 Free PMC article.

4

Reverse immunoediting: When immunity is edited by antigen.

Merlo A, Dalla Santa S, Dolcetti R, Zanovello P, Rosato A. Merlo A, et al. Among authors: dolcetti r. Immunol Lett. 2016 Jul;175:16-20. doi: 10.1016/j.imlet.2016.04.015. Epub 2016 Apr 27. Immunol Lett. 2016. PMID: 27131431 Review.

5

Fighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4⁺ T Cells.

Muraro E, Merlo A, Martorelli D, Cangemi M, Dalla Santa S, Dolcetti R, Rosato A. Muraro E, et al. Among authors: dolcetti r. Front Immunol. 2017 Feb 27;8:197. doi: 10.3389/fimmu.2017.00197. eCollection 2017. Front Immunol. 2017. PMID: 28289418 Free PMC article. Review.

6

Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.

Martorelli D, Muraro E, Merlo A, Turrini R, Rosato A, Dolcetti R. Martorelli D, et al. Among authors: dolcetti r. Int Rev Immunol. 2010 Aug;29(4):371-402. doi: 10.3109/08830185.2010.489658. Int Rev Immunol. 2010. PMID: 20635880 Review.

7

Impact of γ-chain cytokines on EBV-specific T cell cultures.

Merlo A, Turrini R, Trento C, Zanovello P, Dolcetti R, Rosato A. Merlo A, et al. Among authors: dolcetti r. J Transl Med. 2010 Nov 22;8:121. doi: 10.1186/1479-5876-8-121. J Transl Med. 2010. PMID: 21092174 Free PMC article.

8

Immunotherapy for EBV-associated malignancies.

Merlo A, Turrini R, Dolcetti R, Zanovello P, Rosato A. Merlo A, et al. Among authors: dolcetti r. Int J Hematol. 2011 Mar;93(3):281-293. doi: 10.1007/s12185-011-0782-2. Epub 2011 Feb 19. Int J Hematol. 2011. PMID: 21336546

9

A BARF1-specific mAb as a new immunotherapeutic tool for the management of EBV-related tumors.

Turrini R, Merlo A, Martorelli D, Faè DA, Sommaggio R, Montagner IM, Barbieri V, Marin O, Zanovello P, Dolcetti R, Rosato A. Turrini R, et al. Among authors: dolcetti r. Oncoimmunology. 2017 Mar 16;6(4):e1304338. doi: 10.1080/2162402X.2017.1304338. eCollection 2017. Oncoimmunology. 2017. PMID: 28507812 Free PMC article.

10

Exploiting the interplay between innate and adaptive immunity to improve immunotherapeutic strategies for Epstein-Barr-virus-driven disorders.

Martorelli D, Muraro E, Merlo A, Turrini R, Faè DA, Rosato A, Dolcetti R. Martorelli D, et al. Among authors: dolcetti r. Clin Dev Immunol. 2012;2012:931952. doi: 10.1155/2012/931952. Epub 2012 Jan 29. Clin Dev Immunol. 2012. PMID: 22319542 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters